Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Terminated 2Withdrawn 1Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lung Neoplasms 4Glioblastoma 4Uterine Cervical Neoplasms 3Neoplasm Metastasis 3Head and Neck Neoplasms 3Brain Neoplasms 3Rectal Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Lymphoma, B-Cell 2Gliosarcoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Skin Neoplasms 1Sarcoma 1Recurrence 1Pharyngeal Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Neuroblastoma 1Neoplasms 1Mouth Neoplasms 1Meningeal Carcinomatosis 1Melanoma 1

Interventions

Rituximab 9fludarabine phosphate 7Peripheral Blood Stem Cell Transplantation 7Cyclophosphamide 7Whole-Body Irradiation 4Radiotherapy 4Bendamustine Hydrochloride 4Mycophenolic Acid 3Filgrastim 3Cytarabine 3ibrutinib 2fludarabine 2duvelisib 2Tacrolimus 2Pentostatin 2Pentetic Acid 2Methotrexate 2Melphalan 2Lenalidomide 2Etoposide 2Dexamethasone 2Cyclosporine 2Cord Blood Stem Cell Transplantation 2Carmustine 2umbralisib 1ublituximab 1tetulomab tetraxetan lu-177 1sargramostim 1romidepsin 1parsaclisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Lymphoma, B-Cell, Marginal Zone × Radiation × Clear all
NCT04995536 2024-04-25

CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL

City of Hope Medical Center

Phase 1 Withdrawn
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡